Advertisement

Topics

US FDA approves Mvasi for treatment of five types of cancer

09:10 EDT 16 Sep 2017 | PharmaBiz

Amgen and Allergan have announced that the US Food and Drug Administration (FDA) has approved Mvasi (bevacizumab─awwb) for all eligible indications of the reference product, Avastin (bevacizumab).

Original Article: US FDA approves Mvasi for treatment of five types of cancer

NEXT ARTICLE

More From BioPortfolio on "US FDA approves Mvasi for treatment of five types of cancer"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...